Exclusivity Information
Aivlosin holds 2 exclusivitys out of which 1 has expired. Its last outstanding exclusivity is set to expire in 2026. Details of Aivlosin's exclusivity codes and their expiration dates are given below.
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| NCE | Jul 06, 2017 |
| NCI | Oct 13, 2026 |
About Aivlosin
Aivlosin is a drug
owned by ECO LLC
.
Aivlosin uses
Tylvalosin Tartrate as the active
ingredient.
Active Ingredient:
Aivlosin uses
Tylvalosin Tartrate as the active ingredient.
Check out other Drugs and Companies using
Tylvalosin Tartrate ingredient.